• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Cleveland Clinic Florida Opens Florida Research and Innovation Center

by Fred Pennic 07/10/2020 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Cleveland Clinic Florida Opens Florida Research and Innovation Center

What You Should Know:

– Cleveland Clinic Florida opens Florida Research and Innovation Center that will advance innovative translational research, focused on immuno-oncology and infectious diseases, including COVID-19.

– The 107,000-square-foot, state-of-the-art research facility features modern laboratory space, biosafety level 3 facilities for work with infectious agents, and office space for support services on eight acres of land. 


 Cleveland Clinic Florida announced the open of the Florida Research and Innovation Center in Port St. Lucie, Florida that will advance innovative translational research, focused on immuno-oncology and infectious diseases, including COVID-19. The Florida Research and Innovation Center will be closely integrated with Cleveland Clinic’s new Center for Global and Emerging Pathogens Research established in April 2020, which has brought together some of the world’s top research experts in virology, immunology, genomics, and population health to broaden understanding of emerging pathogens – ranging from the Zika virus to SARS-CoV-2 (which causes COVID-19) – and to expedite critically needed treatments and vaccines. The researchers will also collaborate with drug developers at Lerner Research Institute’s Center for Therapeutics Discovery to more rapidly move discoveries out of the laboratory and into the clinic for patient care. 

State of the Art Research Facility

Cleveland Clinic Florida Opens Florida Research and Innovation Center

The 107,000-square-foot, state-of-the-art research facility features modern laboratory space, biosafety level 3 facilities for work with infectious agents, and office space for support services on eight acres of land. Cleveland Clinic has recruited a team of renowned scientists to the Florida Research and Innovation Center to launch scientific programs that address both local and international health challenges, including cancer and emerging pathogens. The facility will additionally provide an exceptional training environment for researchers. Philanthropic funding of this research program will support the new center’s efforts to explore new treatments and technology.

Leadership

The Florida Research and Innovation Center is headed by Scientific Director Michaela Gack, Ph.D., who joined Cleveland Clinic Florida in July 2020. Previously, she was a professor in the Department of Microbiology and chair of the Committee on Microbiology at The University of Chicago in Chicago, Ill. Gack, a renowned virologist, has an extensive background in microbiology and infectious disease. Her research focuses on the immune system’s response to viruses, an essential step in developing safe and effective antivirals and vaccines. She has also done extensive research on immune evasion by Dengue, Influenza and Zika viruses. 

Research Expansion

The Florida Research and Innovation Center will complement and expand research underway at the Florida health system’s five hospitals and the Lerner Research Institute, which is home to 190 laboratories on Cleveland Clinic’s main campus in Cleveland, Ohio. The scientific teams will closely collaborate, tapping into resources at both facilities to develop new treatments for patients around the globe.

“We are pleased to be moving forward with our vision to create a world-class research program in Florida,” said Joseph Iannotti, M.D., Ph.D., Interim CEO and President of Cleveland Clinic Florida and Chief Academic and Innovation Officer. “We are confident that the collaboration between our scientists and partners will ultimately result in the development of therapies that address some of the most challenging medical conditions we face.”  

“Cleveland Clinic’s robust research infrastructure will be further expanded with the opening of the Florida Research and Innovation Center,” said Tom Hamilton, Ph.D., vice chair of Cleveland Clinic’s Lerner Research Institute. “Through team-based discovery, forward-thinking science, translational research, clinical trials and innovation, our vision is to bring together a world-class team of experts within a leading-edge research facility.” 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |